Logo image of GBT.PA

GUERBET (GBT.PA) Stock Fundamental Analysis

Europe - EPA:GBT - FR0000032526 - Common Stock

16.06 EUR
+0.56 (+3.61%)
Last: 10/28/2025, 7:00:00 PM
Fundamental Rating

4

Overall GBT gets a fundamental rating of 4 out of 10. We evaluated GBT against 62 industry peers in the Health Care Equipment & Supplies industry. GBT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GBT has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year GBT was profitable.
GBT had a positive operating cash flow in the past year.
GBT had positive earnings in 4 of the past 5 years.
GBT had a positive operating cash flow in each of the past 5 years.
GBT.PA Yearly Net Income VS EBIT VS OCF VS FCFGBT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

The Return On Assets of GBT (0.76%) is worse than 61.29% of its industry peers.
Looking at the Return On Equity, with a value of 2.06%, GBT is doing worse than 61.29% of the companies in the same industry.
The Return On Invested Capital of GBT (3.17%) is worse than 64.52% of its industry peers.
GBT had an Average Return On Invested Capital over the past 3 years of 4.08%. This is below the industry average of 8.76%.
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROIC 3.17%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
GBT.PA Yearly ROA, ROE, ROICGBT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

GBT has a Profit Margin of 0.96%. This is in the lower half of the industry: GBT underperforms 61.29% of its industry peers.
GBT's Profit Margin has declined in the last couple of years.
The Operating Margin of GBT (4.23%) is worse than 64.52% of its industry peers.
GBT's Operating Margin has declined in the last couple of years.
GBT has a Gross Margin of 78.03%. This is amongst the best in the industry. GBT outperforms 91.94% of its industry peers.
In the last couple of years the Gross Margin of GBT has remained more or less at the same level.
Industry RankSector Rank
OM 4.23%
PM (TTM) 0.96%
GM 78.03%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
GBT.PA Yearly Profit, Operating, Gross MarginsGBT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GBT is destroying value.
Compared to 1 year ago, GBT has about the same amount of shares outstanding.
The number of shares outstanding for GBT has been increased compared to 5 years ago.
GBT has a worse debt/assets ratio than last year.
GBT.PA Yearly Shares OutstandingGBT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
GBT.PA Yearly Total Debt VS Total AssetsGBT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

GBT has an Altman-Z score of 2.07. This is not the best score and indicates that GBT is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.07, GBT perfoms like the industry average, outperforming 41.94% of the companies in the same industry.
The Debt to FCF ratio of GBT is 8.88, which is on the high side as it means it would take GBT, 8.88 years of fcf income to pay off all of its debts.
GBT has a Debt to FCF ratio of 8.88. This is comparable to the rest of the industry: GBT outperforms 45.16% of its industry peers.
GBT has a Debt/Equity ratio of 0.93. This is a neutral value indicating GBT is somewhat dependend on debt financing.
GBT's Debt to Equity ratio of 0.93 is on the low side compared to the rest of the industry. GBT is outperformed by 82.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.88
Altman-Z 2.07
ROIC/WACC0.45
WACC7%
GBT.PA Yearly LT Debt VS Equity VS FCFGBT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 2.32 indicates that GBT has no problem at all paying its short term obligations.
GBT has a Current ratio of 2.32. This is in the better half of the industry: GBT outperforms 64.52% of its industry peers.
GBT has a Quick Ratio of 1.03. This is a normal value and indicates that GBT is financially healthy and should not expect problems in meeting its short term obligations.
GBT has a Quick ratio (1.03) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.03
GBT.PA Yearly Current Assets VS Current LiabilitesGBT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

The earnings per share for GBT have decreased strongly by -76.89% in the last year.
Measured over the past years, GBT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.50% on average per year.
The Revenue has decreased by -2.01% in the past year.
The Revenue has been growing slightly by 0.59% on average over the past years.
EPS 1Y (TTM)-76.89%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%

3.2 Future

The Earnings Per Share is expected to decrease by -6.01% on average over the next years.
Based on estimates for the next years, GBT will show a small growth in Revenue. The Revenue will grow by 3.37% on average per year.
EPS Next Y-70.82%
EPS Next 2Y-22.44%
EPS Next 3Y-12.67%
EPS Next 5Y-6.01%
Revenue Next Year-3.65%
Revenue Next 2Y-0.26%
Revenue Next 3Y1.17%
Revenue Next 5Y3.37%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GBT.PA Yearly Revenue VS EstimatesGBT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
GBT.PA Yearly EPS VS EstimatesGBT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 26.33, which means the current valuation is very expensive for GBT.
Based on the Price/Earnings ratio, GBT is valued a bit cheaper than 67.74% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.83, GBT is valued at the same level.
Based on the Price/Forward Earnings ratio of 10.38, the valuation of GBT can be described as reasonable.
GBT's Price/Forward Earnings ratio is rather cheap when compared to the industry. GBT is cheaper than 91.94% of the companies in the same industry.
GBT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.88.
Industry RankSector Rank
PE 26.33
Fwd PE 10.38
GBT.PA Price Earnings VS Forward Price EarningsGBT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GBT is valued cheaply inside the industry as 98.39% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GBT indicates a rather cheap valuation: GBT is cheaper than 98.39% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.52
EV/EBITDA 4.07
GBT.PA Per share dataGBT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

A cheap valuation may be justified as GBT's earnings are expected to decrease with -12.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-22.44%
EPS Next 3Y-12.67%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.69%, GBT has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.23, GBT pays a better dividend. On top of this GBT pays more dividend than 87.10% of the companies listed in the same industry.
GBT's Dividend Yield is comparable with the S&P500 average which is at 2.30.
Industry RankSector Rank
Dividend Yield 2.69%

5.2 History

The dividend of GBT decreases each year by -10.05%.
Dividend Growth(5Y)-10.05%
Div Incr Years0
Div Non Decr Years1
GBT.PA Yearly Dividends per shareGBT.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

GBT pays out 81.48% of its income as dividend. This is not a sustainable payout ratio.
GBT's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP81.48%
EPS Next 2Y-22.44%
EPS Next 3Y-12.67%
GBT.PA Yearly Income VS Free CF VS DividendGBT.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M
GBT.PA Dividend Payout.GBT.PA Dividend Payout, showing the Payout Ratio.GBT.PA Dividend Payout.PayoutRetained Earnings

GUERBET

EPA:GBT (10/28/2025, 7:00:00 PM)

16.06

+0.56 (+3.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-23 2025-10-23
Earnings (Next)02-04 2026-02-04
Inst Owners15.78%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap203.00M
Revenue(TTM)809.67M
Net Income(TTM)7.74M
Analysts46
Price Target18.61 (15.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.69%
Yearly Dividend0.5
Dividend Growth(5Y)-10.05%
DP81.48%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-30.48%
PT rev (3m)-33.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-70.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-5.99%
Revenue NY rev (3m)-6.03%
Valuation
Industry RankSector Rank
PE 26.33
Fwd PE 10.38
P/S 0.25
P/FCF 4.52
P/OCF 2.17
P/B 0.54
P/tB 0.74
EV/EBITDA 4.07
EPS(TTM)0.61
EY3.8%
EPS(NY)1.55
Fwd EY9.64%
FCF(TTM)3.55
FCFY22.11%
OCF(TTM)7.41
OCFY46.11%
SpS64.06
BVpS29.76
TBVpS21.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.21
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROCE 4.49%
ROIC 3.17%
ROICexc 3.67%
ROICexgc 4.33%
OM 4.23%
PM (TTM) 0.96%
GM 78.03%
FCFM 5.54%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
ROICexc(3y)4.61%
ROICexc(5y)4.69%
ROICexgc(3y)5.43%
ROICexgc(5y)6.06%
ROCE(3y)5.76%
ROCE(5y)5.64%
ROICexgc growth 3Y-4.82%
ROICexgc growth 5Y-5.63%
ROICexc growth 3Y2.13%
ROICexc growth 5Y-2.41%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
F-Score5
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.88
Debt/EBITDA 3.26
Cap/Depr 66.32%
Cap/Sales 6.02%
Interest Coverage 1.61
Cash Conversion 86.9%
Profit Quality 580.05%
Current Ratio 2.32
Quick Ratio 1.03
Altman-Z 2.07
F-Score5
WACC7%
ROIC/WACC0.45
Cap/Depr(3y)72.12%
Cap/Depr(5y)80.72%
Cap/Sales(3y)6.9%
Cap/Sales(5y)7.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.89%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
EPS Next Y-70.82%
EPS Next 2Y-22.44%
EPS Next 3Y-12.67%
EPS Next 5Y-6.01%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%
Revenue Next Year-3.65%
Revenue Next 2Y-0.26%
Revenue Next 3Y1.17%
Revenue Next 5Y3.37%
EBIT growth 1Y-41.57%
EBIT growth 3Y7.37%
EBIT growth 5Y-1.59%
EBIT Next Year61.5%
EBIT Next 3Y25.44%
EBIT Next 5Y21.2%
FCF growth 1Y183.49%
FCF growth 3Y-28.77%
FCF growth 5Y-19.52%
OCF growth 1Y2774.75%
OCF growth 3Y-11.2%
OCF growth 5Y-9.16%

GUERBET / GBT.PA FAQ

What is the ChartMill fundamental rating of GUERBET (GBT.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to GBT.PA.


Can you provide the valuation status for GUERBET?

ChartMill assigns a valuation rating of 5 / 10 to GUERBET (GBT.PA). This can be considered as Fairly Valued.


How profitable is GUERBET (GBT.PA) stock?

GUERBET (GBT.PA) has a profitability rating of 3 / 10.


Can you provide the financial health for GBT stock?

The financial health rating of GUERBET (GBT.PA) is 4 / 10.


How sustainable is the dividend of GUERBET (GBT.PA) stock?

The dividend rating of GUERBET (GBT.PA) is 3 / 10 and the dividend payout ratio is 81.48%.